| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Simplex was founded in April 2007 to provide home delivery of medical supplies to help patients with diabetes.
Stentys is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
It Health Track Inc is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Defend MyDent International is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.